<DOC>
	<DOCNO>NCT02271776</DOCNO>
	<brief_summary>Based hypothesis orally administer GOS ferment SCFA pattern high acetate lead beneficial effect human substrate energy metabolism , aim address follow primary objective : To investigate effect 12-week supplementation GOS peripheral insulin sensitivity body weight control obese adult impair glucose homeostasis .</brief_summary>
	<brief_title>GOS Insulin Sensitivity</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Overweight/obese ( BMI ≥ 28 kg/m2 &lt; 40 kg/m2 ) insulin impair men postmenopausal woman impair glucose tolerance ( IGT : 2h plasma glucose 75g OGTT 7.811.1 mmol/l ) and/or impair fast glucose ( plasma glucose ≥ 5.6 mmol/l ) age 4570 year include study . In addition , subject weightstable least 3 month prior participation ( change bodyweight , i.e . &lt; 3kg ) . diabetes mellitus gastroenterological disease major abdominal surgery ( allow i.e . : appendectomy , cholecystectomy ) lactose intolerance digestive disorder cardiovascular disease , cancer , liver kidney malfunction ( determine base ALAT creatinine level , respectively ) disease life expectancy short 5 year abuse product ( alcohol consumption &gt; 15 units/week , drug ) excessive nicotine use define &gt; 20 cigarette per day</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Insulin Sensitivity</keyword>
</DOC>